These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 367589)

  • 41. [Antigens in the blood serum in pancreatic cancer].
    Vel'bri SK
    Vopr Onkol; 1979; 25(11):28-31. PubMed ID: 516561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases.
    Piantino P; Andriulli A; Gindro T; Pecchio F; Masoero G; Cavallini G; Naccarato R; Dobrilla G
    Am J Gastroenterol; 1986 Jun; 81(6):436-9. PubMed ID: 3458359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer.
    Meduri F; Doni MG; Merenda R; Bizzarini M; Neri D; Gerunda GE; Maffei Faccioli A
    Cancer; 1989 Sep; 64(5):1103-6. PubMed ID: 2667748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Micromethod of the leukocyte adherence inhibition test with a fluorescence evaluation of the results].
    Kurtenkov OA
    Lab Delo; 1979; (1):11-3. PubMed ID: 83428
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunologic diagnosis of human digestive tract cancer. Carcinoembryonic antigens.
    Kamholz SL
    Am J Gastroenterol; 1973 Mar; 59(3):233-43. PubMed ID: 4121819
    [No Abstract]   [Full Text] [Related]  

  • 46. [New data on experimental tumor immunology].
    Schneeweiss U; Gummel H
    Z Exp Chir; 1972; 5(2):66-80. PubMed ID: 4680973
    [No Abstract]   [Full Text] [Related]  

  • 47. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 48. Carbohydrate antigen (CA 19-9)--a valuable tumor marker of pancreatic cancer.
    Lin JT; Wang TH; Sung JL; Chen DS
    Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):828-35. PubMed ID: 3864924
    [No Abstract]   [Full Text] [Related]  

  • 49. Humoral leukocyte adherence inhibition (H-LAI) with basic encephalitogenic protein (BEP) in head and neck cancer.
    Kövesi G; Fekete B
    Haematologia (Budap); 1985; 18(1):27-32. PubMed ID: 2581853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
    MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
    Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Attention to CA 19.9 in alcoholics. Apropos of a case].
    Giovannini M; Penalvert F; Maillot A; Escoffier JM; Botta D; Gauthier A
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):393. PubMed ID: 3481241
    [No Abstract]   [Full Text] [Related]  

  • 52. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
    Schmiegel WH; Kalthoff H
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Summary and future prospects of leukocyte adherence inhibition.
    Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):660-2. PubMed ID: 367591
    [No Abstract]   [Full Text] [Related]  

  • 56. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
    Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
    Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
    [No Abstract]   [Full Text] [Related]  

  • 57. [Leukocyte adhesion inhibition to glass (LAI test) and early diagnosis of pancreatic carcinoma].
    Meduri F; Bizzarini M; Diana F; Gerunda G; Maffei-Faccioli A
    Minerva Chir; 1986 Aug; 41(15-16):1283-8. PubMed ID: 3774173
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical aspects of the CEA test.
    Laurence JR; Neville AM
    Bull Cancer; 1976; 63(4):473-81. PubMed ID: 1021177
    [No Abstract]   [Full Text] [Related]  

  • 59. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
    Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
    Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastrointestinal cancer-associated antigen in immunoperoxidase assay.
    Atkinson BF; Ernst CS; Herlyn M; Steplewski Z; Sears HF; Koprowski H
    Cancer Res; 1982 Nov; 42(11):4820-3. PubMed ID: 6751528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.